URL has been copied successfully!
Lantern Pharma Inc. (NASDAQ:LTRN) shares are trading higher Monday morning. The surge follows a volatile Friday where shares plummeted over 46%.
The company moved quickly to address what it termed “fabricated” information regarding its leadership.
Company Refutes False CEO Resignation
Lantern Pharma issued a statement late Friday to correct a third-party report. The report incorrectly claimed Panna Sharma had stepped down as President and CEO.
“This claim is false, entirely without basis, and appears designed to mislead investors,” the company stated. Lantern confirmed that Sharma remains fully engaged in his roles.
Board Maintains Full Confidence
The Board of Directors clarified they …
This post was originally published here



